RECK Injection for Spine Surgery Pain
What You Need to Know Before You Apply
What is the purpose of this trial?
"RECK" is a combination of local anesthesia medications, used for the purpose of pain control. RECK is an acronym which stands for Ropivacaine, Epinephrine, Clonidine, and Ketorolac. The purpose of this study is to investigate the effect of RECK local injectable anesthetic in the setting of posterior spinal fusion. Our specific aims are the following.Primary aim: to investigate the effect of RECK local injectable anesthetic on postoperative VAS pain scores.Secondary aims: to investigate of effect of RECK injection on postoperative opioid consumption and hospital length of stay.Hypothesis: RECK injection will significantly decrease postoperative VAS pain score, opioid consumption, and hospital length of stay compared to placebo controls.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
How does the RECK injection treatment differ from other spine surgery pain treatments?
The RECK injection for spine surgery pain is unique because it may involve a novel combination of ingredients or a different mechanism of action compared to traditional treatments like corticosteroid injections or opioid-based pain management. While traditional methods focus on reducing inflammation or blocking pain signals, RECK might offer a new approach, potentially involving regenerative medicine techniques, which aim to repair and regenerate damaged tissues.12345
Are You a Good Fit for This Trial?
This trial is for individuals undergoing posterior spinal fusion who have conditions like degenerative disease, various forms of spondylolisthesis, or spinal stenosis. The study will include those eligible based on specific inclusion criteria and exclude anyone not meeting these standards.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the RECK anesthetic cocktail or a placebo injection intraoperatively
Postoperative Monitoring
Participants are monitored for VAS pain scores and opioid consumption during hospital stay
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- RECK
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Maryland, Baltimore
Lead Sponsor